Advertisement
Amazon Lab Supplies
Amazon Lab Supplies

Welcome Back, Pharmalot

The Wall Street Journal revives the popular blog covering pharmaceutical and biotech industry news.

By | June 4, 2014

FLICKR, VELKR0Ed Silverman’s Pharmalot blog is back, with a new home at The Wall Street Journal. Earlier this year (January 2), the blog was shut down by its former parent company, UBM Canon, which shuttered a handful of websites including PharmaLive.com, on which Pharmalot once resided.

In a June 3 post, Silverman said he will continue to cover the pharmaceutical and biotech industries as he has in the past. “And the subject matter will continue to touch on many topical bases—successes and failures as told by executives and patients; R&D challenges; patent skirmishes; marketing wars; government oversight; the use of social media and pricing tussles with payers, to name a few,” he wrote.

Silverman is still sharing industry news on Twitter, @pharmalot.

Clarification (June 5): The subheading on this article has been updated to reflect that the Pharmalot blog is back but was not bought.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. Brain Keeps Watch During Sleep
  4. Locating Language within the Brain
Advertisement
BioRad
BioRad
Advertisement
RayBioTech
LI-COR Biosciences
LI-COR Biosciences